References
1. Abadja, F., B. Sarraj, and M.J. Ansari, Significance of T helper 17
immunity in transplantation. Curr Opin Organ Transplant, 2012.17 (1): p. 8-14.
2. De Meester, I., et al., CD26, let it cut or cut it down.Immunol Today, 1999. 20 (8): p. 367-75.
3. von Bonin, A., J. Huhn, and B. Fleischer, Dipeptidyl-peptidase
IV/CD26 on T cells: analysis of an alternative T-cell activation
pathway. Immunol Rev, 1998. 161 : p. 43-53.
4. Ohnuma, K., N.H. Dang, and C. Morimoto, Revisiting an old
acquaintance: CD26 and its molecular mechanisms in T cell function.Trends Immunol, 2008. 29 (6): p. 295-301.
5. Willheim, M., et al., Cell surface characterization of T lymphocytes
and allergen-specific T cell clones: correlation of CD26 expression with
T(H1) subsets. J Allergy Clin Immunol, 1997. 100 (3): p.
348-55.
6. Fan, H., et al., Dipeptidyl peptidase IV/CD26 in T cell activation,
cytokine secretion and immunoglobulin production. Adv Exp Med
Biol, 2003. 524 : p. 165-74.
7. Boonacker, E.P., et al., CD26/DPPIV signal transduction function, but
not proteolytic activity, is directly related to its expression level on
human Th1 and Th2 cell lines as detected with living cell cytochemistry.J Histochem Cytochem, 2002. 50 (9): p. 1169-77.
8. Reinhold, D., et al., The effect of anti-CD26 antibodies on DNA
synthesis and cytokine production (IL-2, IL-10 and IFN-gamma) depends on
enzymatic activity of DP IV/CD26. Adv Exp Med Biol, 1997.421 : p. 149-55.
9. Yan, S., et al., Enhanced ovalbumin-induced airway inflammation in
CD26-/- mice. Eur J Immunol, 2012. 42 (2): p. 533-40.
10. Yan, S., et al., Deficiency of CD26 results in a change of cytokine
and immunoglobulin secretion after stimulation by pokeweed mitogen.Eur J Immunol, 2003. 33 (6): p. 1519-27.
11. Steinman, L., A brief history of T(H)17, the first major revision in
the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat
Med, 2007. 13 (2): p. 139-45.
12. Wilson, N.J., et al., Development, cytokine profile and function of
human interleukin 17-producing helper T cells. Nat Immunol, 2007.8 (9): p. 950-7.
13. Zheng, Y., et al., Interleukin-22, a T(H)17 cytokine, mediates
IL-23-induced dermal inflammation and acanthosis. Nature, 2007.445 (7128): p. 648-51.
14. Acosta-Rodriguez, E.V., et al., Surface phenotype and antigenic
specificity of human interleukin 17-producing T helper memory cells.Nat Immunol, 2007. 8 (6): p. 639-46.
15. Bengsch, B., et al., Human Th17 cells express high levels of
enzymatically active dipeptidylpeptidase IV (CD26). J Immunol,2012. 188 (11): p. 5438-47.
16. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky, Foxp3 programs the
development and function of CD4+CD25+ regulatory T cells. Nat
Immunol, 2003. 4 (4): p. 330-6.
17. Zhao, X., et al., Delayed allogeneic skin graft rejection in
CD26-deficient mice. Cell Mol Immunol, 2019. 16 (6): p.
557-567.
18. Ohnuma, K., et al., Role of CD26/dipeptidyl peptidase IV in human T
cell activation and function. Front Biosci, 2008. 13 : p.
2299-310.
19. Fan, H., et al., Molecular mechanism and structural basis of
interactions of dipeptidyl peptidase IV with adenosine deaminase and
human immunodeficiency virus type-1 transcription transactivator.Eur J Cell Biol, 2012. 91 (4): p. 265-73.
20. Schwinzer, R., et al., Monoclonal antibodies directed to different
epitopes in the CD3-TCR complex induce different states of competence in
resting human T cells. J Immunol, 1992. 148 (5): p.
1322-8.
21. Ziegler, S.F., F. Ramsdell, and M.R. Alderson, The activation
antigen CD69. Stem Cells, 1994. 12 (5): p. 456-65.
22. Shipkova, M. and E. Wieland, Surface markers of lymphocyte
activation and markers of cell proliferation. Clin Chim Acta,2012. 413 (17-18): p. 1338-49.
23. Mattern, T., et al., Expression of CD26 (dipeptidyl peptidase IV) on
resting and activated human T-lymphocytes. Scand J Immunol, 1991.33 (6): p. 737-48.
24. Ibegbu, C.C., et al., Differential expression of CD26 on
virus-specific CD8(+) T cells during active, latent and resolved
infection. Immunology, 2009. 126 (3): p. 346-53.
25. Hatano, R., et al., CD26-mediated co-stimulation in human CD8(+) T
cells provokes effector function via pro-inflammatory cytokine
production. Immunology, 2013. 138 (2): p. 165-72.
26. Sugie, K., M.S. Jeon, and H.M. Grey, Activation of naive CD4 T cells
by anti-CD3 reveals an important role for Fyn in Lck-mediated signaling.Proc Natl Acad Sci U S A, 2004. 101 (41): p. 14859-64.
27. Ohnuma, K., et al., Blockade of CD26-mediated T cell costimulation
with soluble caveolin-1-Ig fusion protein induces anergy in CD4+T cells.Biochem Biophys Res Commun, 2009. 386 (2): p. 327-32.
28. Cherrier, D.E., N. Serafini, and J.P. Di Santo, Innate Lymphoid Cell
Development: A T Cell Perspective. Immunity, 2018.48 (6): p. 1091-1103.
29. Romagnani, S., T-cell subsets (Th1 versus Th2). Ann Allergy
Asthma Immunol, 2000. 85 (1): p. 9-18; quiz 18, 21.
30. Dang, N.H., et al., Comitogenic effect of solid-phase immobilized
anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.J Immunol, 1990. 144 (11): p. 4092-100.
31. Abbas, A.K., K.M. Murphy, and A. Sher, Functional diversity of
helper T lymphocytes. Nature, 1996. 383 (6603): p.
787-93.
32. Harrington, L.E., et al., Interleukin 17-producing CD4+ effector T
cells develop via a lineage distinct from the T helper type 1 and 2
lineages. Nat Immunol, 2005. 6 (11): p. 1123-32.
33. Hemdan, N.Y., et al., Interleukin-17-producing T helper cells in
autoimmunity. Autoimmun Rev, 2010. 9 (11): p. 785-92.
34. Pinheiro, M.M., et al., Sitagliptin inhibit human lymphocytes
proliferation and Th1/Th17 differentiation in vitro. Eur J Pharm
Sci, 2017. 100 : p. 17-24.
35. Zheng, H.L., et al., Changes in Th17 and IL-17 levels during acute
rejection after mouse skin transplantation. Eur Rev Med Pharmacol
Sci, 2014. 18 (18): p. 2720-86.
36. Yamada, Y., et al., CD26 costimulatory blockade improves lung
allograft rejection and is associated with enhanced interleukin-10
expression. J Heart Lung Transplant, 2016. 35 (4): p.
508-17.
37. Salgado, F.J., et al., CD26: a negative selection marker for human
Treg cells. Cytometry A, 2012. 81 (10): p. 843-55.
38. Ohnuma, K. et al. A
novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.Front Biosci (Landmark Ed) . 2018. 23 :p.1754-1779.